3-(1-(2-methoxybenzyl)piperidin-4-yl)-4-phenyl-3,4-dihydroquinazolin-2(1H)-one

ID: ALA378579

PubChem CID: 19423541

Max Phase: Preclinical

Molecular Formula: C27H29N3O2

Molecular Weight: 427.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1CN1CCC(N2C(=O)Nc3ccccc3C2c2ccccc2)CC1

Standard InChI:  InChI=1S/C27H29N3O2/c1-32-25-14-8-5-11-21(25)19-29-17-15-22(16-18-29)30-26(20-9-3-2-4-10-20)23-12-6-7-13-24(23)28-27(30)31/h2-14,22,26H,15-19H2,1H3,(H,28,31)

Standard InChI Key:  PSPIPEZWCFFHNP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -4.3639  -11.8791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3651  -12.7065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6503  -13.1194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6521  -11.4664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9367  -11.8755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9333  -12.7086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2141  -13.1199    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4937  -12.7027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4971  -11.8696    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2209  -11.4537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2255  -10.6287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5144  -10.2156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5186   -9.3914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2358   -8.9820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9504   -9.4029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9427  -10.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7781  -13.1132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7839  -11.4549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0647  -11.8687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6463  -11.4575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6480  -10.6321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0676  -10.2197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7849  -10.6325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3628  -10.2201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770  -10.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0717  -11.4552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7850  -11.8682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5007  -11.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4987  -10.6268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7847  -10.2176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7804   -9.3927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4928   -8.9764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  4  1  0
 15 16  2  0
 16 11  1  0
  4  1  2  0
  8 17  2  0
  5 10  1  0
  9 18  1  0
 18 19  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  5  6  2  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 10 11  1  0
 21 24  1  0
 24 25  1  0
 11 12  2  0
 25 26  2  0
  2  3  2  0
 26 27  1  0
 12 13  1  0
 27 28  2  0
  3  6  1  0
 28 29  1  0
 13 14  2  0
 29 30  2  0
 30 25  1  0
  1  2  1  0
 30 31  1  0
 14 15  1  0
 31 32  1  0
M  END

Associated Targets(non-human)

SLC8A1 Sodium/calcium exchanger 1 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.55Molecular Weight (Monoisotopic): 427.2260AlogP: 5.30#Rotatable Bonds: 5
Polar Surface Area: 44.81Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.78CX Basic pKa: 7.89CX LogP: 4.45CX LogD: 3.85
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.60Np Likeness Score: -0.76

References

1. Hasegawa H, Muraoka M, Matsui K, Kojima A..  (2006)  A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivatives.,  16  (3): [PMID:16249082] [10.1016/j.bmcl.2005.10.012]

Source